It is known that targeted suppression of NF‐κB activity can disrupt the anti‐apoptotic functions and proliferative activity of HCC cells, which has been regarded as a useful cancer therapeutic approach to prevent the progression of HCC carcinogenesis.16 This evidence concerns the gene NFKB1 and hepatocellular carcinoma.